Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 1/20 | 1.00 |
| ▸ | PPARG | P37231 | 5/20 | 0.85 |
| ▸ | PPARD | Q03181 | 5/20 | 0.85 |
| ▸ | PPARA | Q07869 | 5/20 | 0.85 |
| ▸ | F7 | P08709 | 5/20 | 0.85 |
| ▸ | F3 | P13726 | 5/20 | 0.85 |
| ▸ | TERT | O14746 | 3/20 | 0.85 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.85 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.85 |
| ▸ | FABP4 | P15090 | 3/20 | 0.85 |
| ▸ | MAPT | P10636 | 2/20 | 0.85 |
| ▸ | BLM | P54132 | 2/20 | 0.85 |
| ▸ | LMNA | P02545 | 2/20 | 0.85 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.85 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.85 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.85 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.85 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.85 |
| ▸ | SIRT6 | Q8N6T7 | 2/20 | 0.85 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2140832 | 1.00 | FASN (1.00) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL1870861 | 1.00 | FASN (1.00) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL635133 | 1.00 | FASN (1.00) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL19529657 | 1.00 | FASN (1.00) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL3953180 | 1.00 | FASN (1.00) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL3952605 | 1.00 | FASN (1.00) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL288695 | 1.00 | FASN (1.00) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL3201525 | 1.00 | FASN (1.00) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL20514850 | 1.00 | FASN (1.00) | FASNPPARGPPARDPPARAF7 | |
| SCHEMBL4732554 | 1.00 | FASN (1.00) | FASNPPARGPPARDPPARAF7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007089685-A2 | COMPOSITIONS AND METHODS FOR INDUCING ADIPOSE TISSUE CELL DEATH | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION (US) | 2007-08-09 | — | — | WO | claimed |
| WO-2023213310-A9 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2025-02-20 | — | — | WO | disclosed |
| WO-2023213310-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2023-11-09 | — | — | WO | disclosed |
| CN-115607677-A | Compound for preventing, preventing or treating microbial infection and preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2023-01-17 | — | — | CN | disclosed |
| CN-114788872-A | Compound for preventing, preventing or treating microbial infection and preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-07-26 | — | — | CN | disclosed |
| CN-114569726-A | Compound for preventing, preventing or treating microbial infection and preparation method and application thereof | 太阳雨林(北京)生物医药有限公司 | 2022-06-03 | — | — | CN | disclosed |
| US-20200155575-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2020-05-21 | — | — | US | disclosed |
| US-20190269700-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2019-09-05 | — | — | US | disclosed |
| US-20180104257-A1 | (17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and Use | LIPOCINE INC. (US) | 2018-04-19 | — | — | US | disclosed |
| US-20180078568-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2018-03-22 | — | — | US | disclosed |
| US-20010025113-A1 | Isomer enriched conjugated linoleic acid compositions | AKER BIOMARINE ASA (NO) | 2001-09-27 | — | — | US | disclosed |
| US-20010023259-A1 | Conjugated fatty acids and related compounds | NATURAL ASA | 2001-09-20 | — | — | US | disclosed |
| WO-2001044485-A1 | CONJUGATED FATTY ACIDS AND RELATED COMPOUNDS, AND METHOD FOR THEIR ENZYMATIC PREPARATION | NATURAL ASA (NO) | 2001-06-21 | — | — | WO | disclosed |
| US-6225486-B1 | COMPOSITION COMPRISING MIXTURE OF FREE FATTY ACID CONJUGATED LINOLEIC ACID ISOMERS CONTAINING AT LEAST APPROXIMATELY 92 PER CENT TRANS 10, CIS 12-OCTADECADIENOIC ACID | CONLINCO, INC. | 2001-05-01 | — | — | US | disclosed |
| WO-1999056781-A1 | METHODS OF USING ISOMER ENRICHED CONJUGATED LINOLEIC ACID COMPOSITIONS | CONLINCO, INC. (US) | 1999-11-11 | — | — | WO | disclosed |
| WO-1999056780-A1 | ISOMER ENRICHED CONJUGATED LINOLEIC ACID COMPOSITIONS | CONLINCO, INC. (US) | 1999-11-11 | — | — | WO | disclosed |
| EP-0954975-A2 | Isomer enriched conjugated linoleic acid compositions | ConLinCo, Inc. (US) | 1999-11-10 | — | — | EP | disclosed |
| EP-0954983-A2 | Methods of using isomer enriched conjugated linoleic acid compositions | ConLinCo, Inc. (US) | 1999-11-10 | — | — | EP | disclosed |
| EP-0950410-A1 | Conjugated linoleic acid compositions | ConLinCo, Inc. (US) | 1999-10-20 | — | — | EP | disclosed |
| WO-1999047135-A1 | CONJUGATED LINOLEIC ACID COMPOSITIONS | CONLINCO, INC. (US) | 1999-09-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010025113-A1 | Isomer enriched conjugated linoleic acid compositions | ELOVL1, ELOVL5, ELOVL3 | FASN 67/4885PPARG 103/4885PPARD 440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.